Click here to go to the previous page
Regulatory Capacity Building from 360 Degrees
Program Code:
386
Date:
Wednesday, June 27, 2012
Time:
3:30 PM to 5:00 PM
EST
CHAIR
:
Ekopimo Ibia,
FDA Alumni Association International Network; Merck & Co., Inc., United States
Dr. Ibia is Director & US Regulatory Policy Lead, Merck & Co., Inc. He also is adjunct faculty at John Hopkins. He is former medical reviewer, FDA. He is Board certified in Peds & Peds ID. He holds MPH in Intl. Health Policy from GWU and is Fellow, Royal College of Physicians & Surgeons of Glasgow
|
PRESENTER
(S):
Dr. Bond leads the FDA's strategy on regulatory capacity in the Office of International Programs. She brings over 20 years experience in global health and development, health systems and networks, having held leadership technical and management positions in government, philanthropy, and academia.
|
Paul Tanui, The New Partnership For Africa's Development (NEPAD), South Africa
Lembit Rago,
World Health Organization (WHO), Switzerland
Dr Lembit Rägo was a Professor of Clinical Pharmacology and Director General of the Estonian State Agency of Medicines until joining WHO Geneva in 1999 as Coordinator of Quality Assurance and Safety of Medicines. He is WHO observer to the ICH Steering Committee, ICH GCG and MedDRA MB.
|
Description
Regulatory capacity building is a critical activity to ensure the global access and supply of safe and effective pharmaceuticals. Health authorities, nonprofit entities, and international organizations priorities and activities will be presented.
Learning Objectives:
Identify scientific, regulatory, and technical advances to improve access and availability of pharmaceuticals globally
Discuss organizations, priorities, and efforts in regulatory training
Identify private and public partnerships to advance public health globally.